Urologia Internationalis · 2012 · 34 citations · 21 references
MedicineSurgeryUrologyGenitourinary OncologySurgical OncologyUrologic SurgeryBladder CancerBladder SurgeryGenitourinary Cancer SurgeryUpper Urinary Tract Cancer SurgeryUrologic Oncology SurgeryUrothelial CarcinomaBladder Tumor SurgeryLymphovascular Invasion PrognosisRegional Lymph Node MetastasisUpper Tract RecurrenceUpper Tract Urothelial Carcinoma SurgeryUpper Urinary Tract CytologyUpper Urinary Tract Urothelial Carcinoma SurgeryUrothelial Carcinoma Cytology
OBJECTIVES: To elucidate clinicopathological risk factors for intravesical recurrence (IVR) in patients undergoing nephroureterectomy for upper urinary tract urothelial carcinoma (UUT-UC). METHODS: We identified a study population of 151 consecutive patients without previous or concurrent bladder cancer who underwent nephroureterectomy for UUT-UC. IVR was assessed in relation to tumor location, size, and multifocality, operation modality and time, stage, grade, lymphovascular invasion, regional lymph node metastasis, preoperative urinary cytology, and perioperative chemotherapy. The median follow-up time was 24 months. RESULTS: Of 151 patients, 51 (34%) developed IVR after nephroureterectomy, and 50 (98%) of the patients presented with IVR within 2 years. Tumor multifocality and site (located in ureter) were determined as risk factors for IVR by univariate analysis. In a multivariate analysis, only tumor multifocality (relative risk: 4.024, p = 0.001) was an independent predictor of IVR. Ten-year cancer-specific survival rates for the patients with and without IVR were 68 and 52%, respectively (p = 0.06). CONCLUSIONS: Tumor multifocality is a significant risk factor in developing IVR after surgery for UUT-UC. These results indicate that despite most IVR occurring within 2 years of treatment, it is necessary to follow such patients more closely using cystoscopy. However, IVR is unlikely to indicate a poorer prognosis.
21
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text
Tim O’Brien, Eleanor Ray, Rajinder Singh et al. · European Urology · 2011 · 345 citations
Metachronous multifocal development of urothelial cancers by intraluminal seeding
Tomonori Habuchi, Hiroyuki Yamada, Yasumaro Kakehi et al. · The Lancet · 1993 · 230 citations